HYNEK, David, Ludmila KREJČOVÁ, Ondřej ZÍTKA, Vojtěch ADAM, Libuše TRNKOVÁ, Jiří SOCHOR, Marie STIBOROVÁ, Tomáš ECKSCHLAGER, Jaromír HUBÁLEK and René KIZEK. Electrochemical Study of Doxorubicin Interaction with Different Sequences of Single Stranded Oligonucleotides, Part I. International Journal of Electrochemical Science. 2012, vol. 7, No 1, p. 13-33. ISSN 1452-3981.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Electrochemical Study of Doxorubicin Interaction with Different Sequences of Single Stranded Oligonucleotides, Part I
Authors HYNEK, David (203 Czech Republic), Ludmila KREJČOVÁ (203 Czech Republic), Ondřej ZÍTKA (203 Czech Republic), Vojtěch ADAM (203 Czech Republic), Libuše TRNKOVÁ (203 Czech Republic, belonging to the institution), Jiří SOCHOR (203 Czech Republic), Marie STIBOROVÁ (203 Czech Republic), Tomáš ECKSCHLAGER (203 Czech Republic), Jaromír HUBÁLEK (203 Czech Republic) and René KIZEK (203 Czech Republic, guarantor).
Edition International Journal of Electrochemical Science, 2012, 1452-3981.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10403 Physical chemistry
Country of publisher Serbia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.729 in 2011
RIV identification code RIV/00216224:14310/12:00060306
Organization unit Faculty of Science
UT WoS 000302723700002
Keywords in English intercalating drug; doxorubicin; hetero-nucleotides; square wave voltammetry; adsorptive transfer stripping technique; DNA
Tags AKR, rivok
Changed by Changed by: Mgr. Sylvie Dohnalíková, učo 150911. Changed: 9/1/2013 10:24.
Abstract
Doxorubicin is a known anticancer drug intercalating into dsDNA. The mechanism of interaction of doxorubicin with ssDNA is not clear. In this study, adsorptive transfer stripping technique coupled with square wave voltammetry was used for studying of interaction of doxorubicin with single stranded oligonucleotides (ssODN) in various ratios (1:1, 1:2 and 1:5) and interaction times (0-300 min.). When comparing the results for three ratios of the mixture between drug and ssODN we found that the interval of peak intensities of oligonucleotide reduced with the increasing ratio of oligonucleotide-doxorubicin, i.e. for ratio 1:1 it is 25-85 %, for ratio 1:2 it is 16-60 % and for ratio 1:5 it is 19-51 %. The interval of relative signal intensities of doxorubicin ranges from 8 to 100 % for ratio 1:1, 22-100 % for ratios 1:2 and 1:5. The results showed the assumption that DOXO peak height increased with increasing concentration of the drug intercalated into ssODN, but the signals CA peaks changes during the interaction suggest the changes in the structure of ssODN.
PrintDisplayed: 31/8/2024 12:44